Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03462758 · ClinicalTrials.gov registry record · NA

Early vs. Interval Postpartum IUD Insertion

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
404
Enrollment target

NCT03462758: Completed NA study, sponsored by University of California, San Diego.

NCT03462758 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 404 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03462758, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
404 participants
Enrollment target

Study Summary

Intrauterine devices (IUDs) are historically placed at a six-week postpartum visit for women who desire intrauterine contraception after delivery. A two-week postpartum visit could be a convenient time for women to receive contraception, including IUDs. Offering women IUDs at two-weeks postpartum may decrease the risk of undesired pregnancy and rapid repeat pregnancy. This study will compare IUD insertion at two different times after delivery: two-weeks and six-weeks postpartum. This will allow researchers to assess whether the timing of IUD placement affects whether an IUD is expelled, or pushed out of it's ideal location.

Primary Outcome

Complete IUD expulsion will be defined as an IUD which no longer in the uterus on speculum exam and transvaginal ultrasound will be performed on all patients at 6 months postpartum to confirm IUD use

Interventions

  • DEVICE IUD

Trial Details

FieldValue
Enrollment Target 404 participants
Start Date 2018-03-20
Est. Completion 2022-12-31
Phase NA
University of California, San Diego

775 total trials

What the finished NCT03462758 record still lists

NCT03462758 is an interventional study that assigns participants to a tested intervention. The registered 404 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).

The record links to 0 conditions, and to 1 intervention - of which IUD is the first listed.

NCT03462758 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03462758 about?

NCT03462758 is a clinical study titled "Early vs. Interval Postpartum IUD Insertion". Intrauterine devices (IUDs) are historically placed at a six-week postpartum visit for women who desire intrauterine contraception after delivery. A two-week postpartum visit could be a convenient time for women to receive contraception, including IUDs. Offering women IUDs at two-weeks postpartum ma...

What is the current status of trial NCT03462758?

This trial is currently completed. It is a NA study. The enrollment target is 404 participants. The study started on 2018-03-20. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT03462758?

The interventions under investigation include: IUD (DEVICE).

Who is sponsoring clinical trial NCT03462758?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03462758's enrollment target sits among peer trials

404 244th of 2000 higher than 1,757 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05049057 · 404 participants · Phase 2

    Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

  • NCT05611242 · 404 participants · Phase 3

    Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

  • NCT06072612 · 404 participants · Phase 3

    Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • NCT05576350 · 405 participants · NA

    TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03462758, the US trial registry maintained by the National Library of Medicine. NCT03462758 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.